New study tracks psoriasis Drug's Real-World impact on diverse skin types

NCT ID NCT07370766

First seen Jan 27, 2026 · Last updated May 14, 2026 · Updated 13 times

Summary

This study observes 80 adults in Canada with moderate-to-severe psoriasis who are starting tildrakizumab as part of their routine care. Researchers will track changes in quality of life and skin clearance over 52 weeks, focusing on people with Fitzpatrick skin types III and above. The goal is to understand how well the drug works in real-world settings and in diverse populations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS (PSO) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Burlington Skin and Wellness

    RECRUITING

    Burlington, Ontario, L7L 3E5, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Centricity Research London Victoria Multispecialty

    RECRUITING

    London, Ontario, N6A 2C2, Canada

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Factor Dermatology

    RECRUITING

    Ottawa, Ontario, K2A 3Z3, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Locke Dermatology

    RECRUITING

    Hamilton, Ontario, L8P 4B4, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Panorama Dermatology Clinic

    RECRUITING

    Kanata, Ontario, K2T 0N7, Canada

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Saskatoon Dermatology Centre

    RECRUITING

    Saskatoon, Saskatchewan, S7T0G3, Canada

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.